| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $67.8M | +44.4% |
| SG&A Expense | $23.6M | -3.4% |
| Operating Income | -$91.4M | -28.0% |
| Interest Expense | $302K | +0.0% |
| Pre-tax Income | -$85.2M | -21.4% |
| Income Tax | $852K | -33.1% |
| Net Income | -$86.1M | -20.5% |
| EPS (Basic) | -$1.98 | +20.2% |
| EPS (Diluted) | -$1.98 |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $143.2M | +0.4% |
| Current Assets | $147.3M | -0.7% |
| Total Assets | $150.7M | -0.7% |
| Current Liabilities | $15.7M | +47.2% |
| Total Liabilities | $17.6M | +35.6% |
| Stockholders' Equity | $133.2M | -4.1% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$71.7M | -20.1% |
| Capital Expenditures | $323K | -53.2% |
| Investing Cash Flow | -$323K | +53.2% |
| Financing Cash Flow | $71.9M | — |
| Free Cash Flow | -$72.1M | -19.3% |
| +20.2% |